Cargando…

Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer

Lactate accumulation in tumors has been associated with metastases and poor overall survival in cancer patients. Lactate promotes angiogenesis and metastasis, providing rationale for understanding how it is processed by cells. The concentration of lactate in tumors is a balance between the amount pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Kelly M., Scarbrough, Peter M., Ribeiro, Anthony, Richardson, Rachel, Yuan, Hong, Sonveaux, Pierre, Landon, Chelsea D., Chi, Jen-Tsan, Pizzo, Salvatore, Schroeder, Thies, Dewhirst, Mark W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771963/
https://www.ncbi.nlm.nih.gov/pubmed/24069390
http://dx.doi.org/10.1371/journal.pone.0075154
_version_ 1782284254793695232
author Kennedy, Kelly M.
Scarbrough, Peter M.
Ribeiro, Anthony
Richardson, Rachel
Yuan, Hong
Sonveaux, Pierre
Landon, Chelsea D.
Chi, Jen-Tsan
Pizzo, Salvatore
Schroeder, Thies
Dewhirst, Mark W.
author_facet Kennedy, Kelly M.
Scarbrough, Peter M.
Ribeiro, Anthony
Richardson, Rachel
Yuan, Hong
Sonveaux, Pierre
Landon, Chelsea D.
Chi, Jen-Tsan
Pizzo, Salvatore
Schroeder, Thies
Dewhirst, Mark W.
author_sort Kennedy, Kelly M.
collection PubMed
description Lactate accumulation in tumors has been associated with metastases and poor overall survival in cancer patients. Lactate promotes angiogenesis and metastasis, providing rationale for understanding how it is processed by cells. The concentration of lactate in tumors is a balance between the amount produced, amount carried away by vasculature and if/how it is catabolized by aerobic tumor or stromal cells. We examined lactate metabolism in human normal and breast tumor cell lines and rat breast cancer: 1. at relevant concentrations, 2. under aerobic vs. hypoxic conditions, 3. under conditions of normo vs. hypoglucosis. We also compared the avidity of tumors for lactate vs. glucose and identified key lactate catabolites to reveal how breast cancer cells process it. Lactate was non-toxic at clinically relevant concentrations. It was taken up and catabolized to alanine and glutamate by all cell lines. Kinetic uptake rates of lactate in vivo surpassed that of glucose in R3230Ac mammary carcinomas. The uptake appeared specific to aerobic tumor regions, consistent with the proposed “metabolic symbiont” model; here lactate produced by hypoxic cells is used by aerobic cells. We investigated whether treatment with alpha-cyano-4-hydroxycinnamate (CHC), a MCT1 inhibitor, would kill cells in the presence of high lactate. Both 0.1 mM and 5 mM CHC prevented lactate uptake in R3230Ac cells at lactate concentrations at ≤20 mM but not at 40 mM. 0.1 mM CHC was well-tolerated by R3230Ac and MCF7 cells, but 5 mM CHC killed both cell lines ± lactate, indicating off-target effects. This study showed that breast cancer cells tolerate and use lactate at clinically relevant concentrations in vitro (± glucose) and in vivo. We provided additional support for the metabolic symbiont model and discovered that breast cells prevailingly take up and catabolize lactate, providing rationale for future studies on manipulation of lactate catabolism pathways for therapy.
format Online
Article
Text
id pubmed-3771963
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-37719632013-09-25 Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer Kennedy, Kelly M. Scarbrough, Peter M. Ribeiro, Anthony Richardson, Rachel Yuan, Hong Sonveaux, Pierre Landon, Chelsea D. Chi, Jen-Tsan Pizzo, Salvatore Schroeder, Thies Dewhirst, Mark W. PLoS One Research Article Lactate accumulation in tumors has been associated with metastases and poor overall survival in cancer patients. Lactate promotes angiogenesis and metastasis, providing rationale for understanding how it is processed by cells. The concentration of lactate in tumors is a balance between the amount produced, amount carried away by vasculature and if/how it is catabolized by aerobic tumor or stromal cells. We examined lactate metabolism in human normal and breast tumor cell lines and rat breast cancer: 1. at relevant concentrations, 2. under aerobic vs. hypoxic conditions, 3. under conditions of normo vs. hypoglucosis. We also compared the avidity of tumors for lactate vs. glucose and identified key lactate catabolites to reveal how breast cancer cells process it. Lactate was non-toxic at clinically relevant concentrations. It was taken up and catabolized to alanine and glutamate by all cell lines. Kinetic uptake rates of lactate in vivo surpassed that of glucose in R3230Ac mammary carcinomas. The uptake appeared specific to aerobic tumor regions, consistent with the proposed “metabolic symbiont” model; here lactate produced by hypoxic cells is used by aerobic cells. We investigated whether treatment with alpha-cyano-4-hydroxycinnamate (CHC), a MCT1 inhibitor, would kill cells in the presence of high lactate. Both 0.1 mM and 5 mM CHC prevented lactate uptake in R3230Ac cells at lactate concentrations at ≤20 mM but not at 40 mM. 0.1 mM CHC was well-tolerated by R3230Ac and MCF7 cells, but 5 mM CHC killed both cell lines ± lactate, indicating off-target effects. This study showed that breast cancer cells tolerate and use lactate at clinically relevant concentrations in vitro (± glucose) and in vivo. We provided additional support for the metabolic symbiont model and discovered that breast cells prevailingly take up and catabolize lactate, providing rationale for future studies on manipulation of lactate catabolism pathways for therapy. Public Library of Science 2013-09-12 /pmc/articles/PMC3771963/ /pubmed/24069390 http://dx.doi.org/10.1371/journal.pone.0075154 Text en © 2013 Kennedy et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Kennedy, Kelly M.
Scarbrough, Peter M.
Ribeiro, Anthony
Richardson, Rachel
Yuan, Hong
Sonveaux, Pierre
Landon, Chelsea D.
Chi, Jen-Tsan
Pizzo, Salvatore
Schroeder, Thies
Dewhirst, Mark W.
Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title_full Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title_fullStr Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title_full_unstemmed Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title_short Catabolism of Exogenous Lactate Reveals It as a Legitimate Metabolic Substrate in Breast Cancer
title_sort catabolism of exogenous lactate reveals it as a legitimate metabolic substrate in breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771963/
https://www.ncbi.nlm.nih.gov/pubmed/24069390
http://dx.doi.org/10.1371/journal.pone.0075154
work_keys_str_mv AT kennedykellym catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT scarbroughpeterm catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT ribeiroanthony catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT richardsonrachel catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT yuanhong catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT sonveauxpierre catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT landonchelsead catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT chijentsan catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT pizzosalvatore catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT schroederthies catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer
AT dewhirstmarkw catabolismofexogenouslactaterevealsitasalegitimatemetabolicsubstrateinbreastcancer